A tactical playbook for aggregating cash-pay IV therapy clinics in a highly fragmented, high-growth wellness vertical before the consolidation window closes.
Find IV Therapy Clinic Platform TargetsMarket Size
Estimated $8–$11 billion U.S. market as of 2024, growing rapidly from a base of under $2 billion in 2018
Growth Trend
Growing
Market Structure
Highly fragmented
Recession Resistant
No
The U.S. IV therapy market is highly fragmented with thousands of independent owner-operated clinics generating $1M–$3M in revenue. Most lack institutional infrastructure, creating an opportunity for disciplined acquirers to build a branded multi-location platform, centralize operations, and exit to a larger med spa group or wellness PE platform at premium multiples.
IV therapy clinics trade at 3–5.5x EBITDA individually but command 6–8x at scale. The market is fragmented, barriers to entry exist through medical director relationships and state licensing, and membership-based revenue models create predictable cash flow that institutional buyers prize when evaluating platform exits.
Minimum $500K EBITDA with Clean Financials
Platform target must show at least $500K trailing EBITDA with three years of accrual-based CPA-prepared statements and no significant revenue concentration in a single client or contract.
Transferable Medical Director Agreement
A licensed physician medical director with a documented, assignable supervision agreement is non-negotiable. Owner must not be the sole medical director or primary clinical provider.
Active Membership Program with 200+ Members
Platform clinics must demonstrate recurring revenue through a structured membership program with documented retention rates, monthly churn metrics, and at least 200 active paying members.
Multi-Location or Expansion-Ready Infrastructure
Ideal platform has 2+ locations or a proven single-location model with documented SOPs, a trained clinical team, and a brand identity scalable across new geographies.
Single-Location Clinic with Loyal Client Base
Independent clinics with strong local reputation, 4.8+ star reviews, and 100+ recurring clients are ideal add-ons even if pre-membership, provided clinical compliance is clean.
Mobile IV Therapy Operation with Recurring Contracts
Mobile units with corporate wellness, hotel, or event contracts extend geographic reach and diversify revenue without requiring new fixed-location buildout or additional state licensing.
Clinic with Complementary Services like NAD+ or Weight Loss
Add-ons offering NAD+ infusions, peptide therapy, or GLP-1 weight loss programs increase revenue per visit and cross-sell opportunity across the platform's existing membership base.
Distressed Clinic with Regulatory or Transition Risk
Owner-dependent clinics facing medical director turnover or founder retirement can be acquired at discounted multiples and stabilized using the platform's compliance infrastructure and physician network.
Build your IV Therapy Clinic roll-up
DealFlow OS surfaces off-market IV Therapy Clinic targets with seller signals — the foundation of every successful roll-up.
Centralize Medical Director and Compliance Infrastructure
A platform-level medical director agreement covering all locations reduces per-clinic compliance costs, eliminates key-person risk, and satisfies corporate practice of medicine requirements across jurisdictions.
Standardize Membership Programs Across All Locations
Deploying a unified tiered membership model across acquired clinics increases predictable recurring revenue, improves retention, and makes the platform's cash flow story compelling to exit buyers.
Centralize Pharmaceutical and Supply Procurement
Consolidating compounding pharmacy and IV supply agreements across locations drives 10–20% cost reductions, reduces FDA compliance exposure, and creates a defensible operational advantage over independent competitors.
Build a Shared Services Layer for Back-Office Functions
Centralizing billing, scheduling, marketing, and HR across locations eliminates redundant owner-operator overhead, expands EBITDA margins, and creates a scalable infrastructure that supports rapid add-on integration.
Med spa or wellness platform operator executing a geographic rollup strategy, a retiring physician adding a complementary cash-pay service line, or a first-time buyer with a healthcare or nursing background seeking an owner-operator lifestyle business with SBA financing
Buyer Acquisition Criteria
Minimum $500K EBITDA preferred, established medical director agreement with transferable structure, at least 2 years of operating history, documented clinical protocols, cash-pay revenue model with no insurance dependency, and a proven recurring customer base with membership programs
Why this industry is defensible post-acquisition and at exit.
Successful IV Therapy Clinic roll-ups typically cluster acquisitions within a defined geographic radius before expanding into new markets. Starting in a single metro area allows a roll-up operator to share back-office infrastructure, management talent, and vendor relationships across multiple locations before the fixed cost of replication makes national expansion viable. Buyers who attempt multi-market simultaneous expansion typically dilute management attention and lose the margin compression benefits that justify roll-up valuations at exit.
The platform acquisition should anchor the geographic cluster — it sets the operational standard, supplies management depth, and establishes local market credibility that makes add-on seller outreach more effective. Add-on targets within a 50–100 mile radius of the platform tend to show the highest post-close retention of staff and clients.
A 4–6 location IV therapy platform generating $2M–$4M EBITDA is a compelling acquisition target for med spa PE platforms, concierge medicine groups, or national wellness franchises. At scale, expect exit multiples of 6–8x EBITDA, delivering a 2–3x multiple expansion versus entry pricing on individual clinic acquisitions.
Roll-up operators in the IV Therapy Clinic space typically target a 3–5 year hold with an exit to a strategic buyer or PE-backed platform at a multiple 1.5–3× higher than individual business entry multiples. The multiple expansion between the blended entry multiple and exit multiple — often called the “arbitrage spread” — is the primary source of equity returns in a well-executed roll-up strategy. Documenting standardized operations, management depth, and recurring revenue quality before going to market is critical to achieving the upper end of exit multiple expectations.
Most platform-quality IV therapy clinics trade at 3.5–5x EBITDA. Acquiring at 4x and exiting a multi-location platform at 6–8x creates meaningful multiple expansion for rollup investors.
CPOM laws vary by state and may require a physician-owned entity structure or management services agreement. Engage a healthcare attorney before acquiring in new states to avoid costly restructuring post-close.
SBA 7(a) loans are available for individual clinic acquisitions but cannot fund equity rollup structures. Subsequent add-ons may require conventional debt or PE equity as the platform scales beyond SBA eligibility thresholds.
Medical director transitions and nurse staff retention are the highest-risk integration points. Secure physician agreements and offer retention bonuses to clinical staff before closing any add-on acquisition.
More IV Therapy Clinic Guides
DealFlow OS surfaces off-market platform targets with seller motivation scores. Free to join.
Find platform targets — freeNo credit card required
For Buyers
For Sellers